BG Medicine, Inc. (BGMD)

Market Cap	11.00 -99.0%
Revenue (ttm)	1.57M -43.8%
Net Income	-6.96M
EPS	-0.72
Shares Out	11.37M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	601
Open	0.000001
Previous Close	0.0001
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.0001
Beta	65.16
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About BG Medicine

BG Medicine, Inc., a diagnostics company, engages in the development and commercialization of novel cardiovascular diagnostic tests to address unmet medical needs in the United States, Europe, and internationally. It offers BGM Galectin-3 test, a novel diagnostic test that measures galectin-3 in blood plasma or serum; and CardioSCORE test that is designed to identify cardiovascular events, such as heart attack and stroke. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medici...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 5
• Stock Exchange: OTCMKTS
• Ticker Symbol: BGMD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 19, 2026

Data Sources Report a data error